Background. Platelet-derived growth factor (PDGF)-B regulates mesangial cell and vessel development during embryogenesis, and contributes to the pathogenesis of adult renal and vascular diseases. Endothelial cell PDGF-B exerts paracrine effects on mesangial cells, but its regulation is not well defined. We examined the impact of hypoxia on PDGF-B-mediated interactions between glomerular endothelial and mesangial cells, a condition of potential relevance in developing, and diseased adult, kidneys.
The cytokine platelet-derived growth factor (PDGF)-B plays a critical role in glomerular maturation and blood vessel formation during embryonic life, and contributes to the pathogenesis of adult diseases such as glomerulosclerosis and atherosclerosis. Studies in mice lacking PDGF-B demonstrated its importance during normal embryogenesis [1] . Microaneurysms were noted in numerous capillary beds, including the glomerulus, which totally lacked mesangial cells. The aneurysmal dilatations were attributed to the absence of perivascular cells, such as mesangial cells, which provide structural support for developing blood vessels [2] .
In the developing kidney, PDGF-B appears to act in a paracrine fashion. Lindahl et al [3] demonstrated by in situ hybridization that endothelial cells invading the cleft of the developing glomerulus expressed transcripts for PDGF-B, but not the PDGF-b receptor. Conversely, mesangial cell precursors expressed mRNA only for the PDGF-b receptor. The authors therefore hypothesized that glomerular endothelial cell PDGF-B acts in a paracrine fashion on adjacent mesangial cells, allowing for comigration and localization of these cells to the glomerulus. Although PDGF-B also is produced by fetal podocytes and by mesangial cells themselves [4] , the requirement for endothelial PDGF-B in mesangial cell development was recently demonstrated [5] . Mice lacking endothelial PDGF displayed a renal phenotype reminiscent of the pdgf−/− mice (i.e., absent or markedly reduced numbers of mesangial cells). Further supporting these results, absence of glomerular endothelial cells in mutant cloche zebrafish [6] or in Notch2 del1 mice [7] was associated with the lack of detectable mesangial cells. Thus, endothelial cell-derived PDGF-B is critical for mesangial cell development.
It is not currently understood what regulates the expression of PDGF-B in the nascent glomerular capillaries during renal development. Of the many inducers that regulate PDGF-B, some, such as transforming growth factorb (TGF-b) [8] and basic fibroblast growth factor (bFGF) [9] , also play important roles during embryogenesis. Low tissue oxygen tension during fetal life stimulates angiogenesis, and hypoxia potently induces PDGF-B gene transcription in human umbilical vein endothelial cells (HUVECs) [10] and pulmonary artery endothelial cells [11] . Although as yet no reports have described a similar response in glomerular capillary endothelial cells, it is important to note that Freeburg et al [12, 13] demonstrated that the developing kidney stained positive for pimonidazole hydrochloride, a marker which becomes detectable under conditions of severe hypoxia.
While PDGF-B is essential for normal embryonic vessel formation, the cytokine also plays a pathogenic role in renal diseases of the mature kidney. PDGF-B stimulates mesangial cell proliferation, which in turn, leads to increased matrix production and ultimately glomerulosclerosis. In the Thy 1 model of mesangioproliferative nephritis, PDGF-B transcripts and protein are increased in the glomeruli of diseased rats [14] [15] [16] . We demonstrated that infusion of PDGF-B recapitulated these findings [17] ; and administration of PDGF-B neutralizing antibody abrogated glomerulosclerosis [18] , supporting an etiologic function for PDGF-B. In human glomerular disease characterized by mesangial cell proliferation, PDGF-B also appears to play a role (reviewed in [19] ).
PDGF-B is regulated by effectors in pathogenic pathways, such as thrombin [20] , tumor necrosis factor (TNF) [21] , interleukin (IL)-6 [22] , and high glucose [23] . However, the impact of hypoxia on PDGF-mediated mesangial cell responses in renal diseases has not been studied. There has been increased recognition of endothelial cell damage in progressive renal diseases (reviewed in [24] ) and glomerular hypoxia may occur as a consequence of loss of the microvasculature or from microthrombus formation. In several animal models of glomerular disease, the loss of glomerular endothelium correlates with the development of sclerosis [25, 26] .
Since low oxygen tension appears to be present in the developing kidney and hypoxia may be present in glomerular diseases in the adult, we investigated whether hypoxia is a regulator of PDGF-B interactions between glomerular capillary endothelial and mesangial cells. Our results demonstrate that hypoxia increases glomerular capillary endothelial cell PDGF-B and that hypoxia enhances mesangial cell proliferation and migration in response to PDGF-B. We further show that while hypoxia does not increase total cellular PDGF-b receptor levels, it results in increased specific binding capacity.
METHODS

Cells
Bovine glomerular capillary endothelial (CH1a) cells were isolated from the kidneys of calves less than 1 year old, using a modification of a previously described [27] method. Glomeruli from cortical slices were isolated by sieving, then digested with type IV collagenase (Worthington Biochemical Corp., Freehold, NJ, USA). Glomerular digests were plated onto plastic culture dishes coated with 0.2% gelatin (Sigma Chemical Co., St. Louis, MO, USA) and incubated with 20% fetal bovine serum (FBS) in RPMI-1640 medium with 12 lg/mL bovine brain extract (Clonetics, San Diego, CA, USA), 10 ng/mL acidic FGF (R&D Systems, Minneapolis, MN, USA), 2.6 lg/mL heparin, 1100 U/mL penicillin-100 lg/mL streptomycin, and 2.5 lg/mL amphotericin. Amphotericin was removed from the media after 2 to 3 weeks. When dishes were approximately 60% to 70% confluent, cells were incubated for 3 hours with 10 lg/mL DiI-labeled acetylated low-density lipoprotein (ac-LDL) (BTI, Stoughton, MA, USA). Cells were trypsinized, sorted by fluorescence-activated cell sorting (FACS) using sterile techniques and postsort analysis was performed on positive cells. Ac-LDL-positive cells were plated on dishes as above, and growth medium was changed three times per week. One week after ac-LDL-positive cells were plated, penicillin in the growth medium was reduced to 200 U/mL. Cells were confirmed as endothelial by classical morphology, positive immunostaining for von Willebrand factor (vWF) (Dako, Carpinteria, CA, USA), and negative staining for alpha smooth muscle actin (a-SMA) (Sigma Chemical Co.). Medium was changed three times per week, and cells were used between passages 5 and 20.
Rat mesangial cells were isolated from glomerular digests isolated through sieving as above. Cells were confirmed as mesangial by positive a-SMA and negative vWF immunostaining. Cells were maintained in 15% FBS in RPMI-1640, with 2 mmol/L L-glutamine, 15 mmol/L Hepes buffer, 1 mmol/L sodium pyruvate, 1 mg/mL sodium bicarbonate, 8 lg/mL insulin, and 92 lg/mL Dvaline. Medium was changed three times per week, and cells were used up to passage 22.
Hypoxia experiments
Cells maintained under normoxic conditions were incubated in standard humidified 5.5% CO 2 incubators (21% O 2 ). Hypoxic conditions (1.5% or 3% O 2 , 5% CO 2 , balance nitrogen) were achieved in a humidified variable aerobic workstation (InVIVO 2 ) (Ruskinn Technology, Leeds, UK) or in modular sealed hypoxia chambers (Billups-Rothenberg, Inc., Del-Mar, CA, USA) filled with premixed gases.
Northern analysis
Glomerular capillary endothelial CH1a cells in confluent 100 mm dishes were incubated overnight in medium containing 0.5% FBS, then transferred to hypoxic chambers. After hypoxic exposure from 1 to 32 hours, cells were lysed in Trizol (Gibco BRL Life Technologies, Gaithersburg, MD, USA) and total RNA isolated according to the manufacturer's directions. Time-matched controls were cells maintained in normoxia. Ten micrograms total RNA per sample were resolved on a 1% agarose gel, followed by capillary blotting transfer to a nylon membrane. Membranes were prehybrized at 65
• C in Rapid Hyb (Amersham, Piscataway, NJ, USA), hybridized overnight with the appropriate 32 P-deoxycytidine triphosphate (dCTP)-labeled probe, then washed. Steps conducted at 65
• C for cDNA probes were conducted at 42
• C for oligonucleotide probes. The blots were then exposed to Kodak X-AR film (Eastman Kodak, Rochester, NY, USA) and analyzed using the PhosphorImage system (Molecular Dynamics, Sunnyvale, CA, USA).
The following probes were used: a 2.0 kb PDGF-B cDNA probe isolated from pcDU1, a 2.1 kb vascular endothelial growth factor (VEGF) cDNA probe isolated from pT7T3D-Pac (both from American Type Culture Collection, Rockville, MD, USA), and an oligonucleotide 18S rRNA probe (Integrated DNA Technology, Coralville, IA, USA). cDNA probes were labeled using a random priming system (Invitrogen, Carlsbad, CA, USA or Amersham) and oligonucleotide probes using terminal deoxynucleotidyl transferase (Life Technologies). Densitometry was performed using the ImageQuant software program (Molecular Dynamics).
Immunoblotting
Quiescent endothelial cells in 100 mm dishes were subjected to hypoxia as before. Dishes were rinsed twice with cold phosphate-buffered saline (PBS), then snap-frozen in liquid nitrogen. After rapidly thawing in a 37
• C water bath, cells were lysed in RIPA buffer [50 mmol/L TrisHCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mmol/L NaCl, 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 1 lg/mL each of aprotinin, leupeptin, and pepstatin, 1 mmol/L sodium orthovanadate, and 1 mmol/L sodium fluoride]. In other experiments, nuclear extracts were isolated as previously described [28] . Briefly, thawed cell lysates were incubated in water with 0.03% igepal (Sigma Chemical Co.) and protease inhibitors for 15 minutes on ice. Samples were pelleted at 14,000 × g, the supernatant removed and nuclei lysed in 20 mmol/L Hepes, 25% glycerol, 420 mmol/L NaCl, 1.5 mmol/L magnesium chloride, and 0.2 mmol/L EDTA. Nuclear proteins were obtained following a second brief centrifugation.
Ten to 25 micrograms of protein per sample were electrophoresed through acrylamide gels, then transferred to polyvinylidene fluoride (PVDF) membranes, and blocked for 1 hour at room temperature with 3% bovine serum albumin (BSA) (Midwest Scientific, St. Louis, MO, USA) or 5% milk (Bio-Rad, Hercules, CA, USA). Membranes were incubated overnight at 4
• C with primary antibody, and for 1 hour at room temperature with the appropriate horseradish peroxidaseconjugated secondary antibody. Proteins were analyzed using the chemiluminescence technique (Amersham; or Pierce Biotechnology, Rockford, IL, USA). Primary antibodies included rabbit polyclonal antibodies to human PDGF-B, PDGF-b receptor, nuclear factor-jB (NF-kB), c-jun (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and hypoxia-inducible factor-1a (HIF-1a( (Novus Biologicals, Littleton, CO, USA). Secondary antibodies were horseradish peroxidase-conjugated antibodies against the appropriate species (Santa Cruz Biotechnology).
Assessment of proliferation
Confluent mesangial cells plated into 24-well culture dishes were quiesced in serum-free medium for 48 hours. Cells were then transferred to hypoxic chambers or maintained in normoxia as above and stimulated with varying concentrations of PDGF-BB (R&D Systems) or vehicle for 24 hours. Incorporation of 3 H-thymidine following a 4-hour pulse at the end of the 24-hour treatment was determined. Each experiment consisted of six replicates of each condition, and mean and standard deviation (SD) were calculated for each experiment.
Migration assays
Confluent mesangial cells were maintained in serumfree medium for 48 hours, then either subjected to hypoxia or maintained in normoxia for the last 24 hours. Cells were trypsinized, and 50,000 cells resuspended in 2% serum were seeded onto 6.5 mm 8 lm pore polycarbonate transwell filters (Corning Costar, Corning, NY, USA). The filters were placed into wells containing either 50 ng/mL PDGF-BB or vehicle. In other experiments, the wells contained cell-free media conditioned by endothelial cells, with or without pre-incubation with PDGF-B neutralizing antibody (goat antihuman PDGF-BB, 0.1 lg/mL) or irrelevant goat IgG (0.1 lg/mL). Mesangial cells were allowed to migrate, then filters were removed, and the apical surface washed twice with PBS. Cells remaining on the apical surface were removed by gentle swabbing with a cotton-tipped applicator. Cells that had migrated to the undersurface of the filter were fixed, Giemsa stained, and cells in nine consecutive central fields at 200× magnification were counted.
Binding studies
Quiescent normoxic or hypoxic mesangial cells were washed twice with PBS, then treated briefly with glycine (20 mmol/L)-saline (125 mmol/L NaCl) buffer (pH 3.0) to strip off any PDGF-B binding to surface receptors, followed by two rinses with binding buffer (25 mmol/L Hepes and 2 mg/mL BSA in RPMI, pH 7.4). Cells were then incubated with varying concentrations of 125 I-PDGF (Amersham) for 2 hours at room temperature on an orbital shaker at 120 rpm. Hypoxic cells were maintained in hypoxia for the incubation period. Cell-associated radioactivity was measured after lysing in solubilization buffer containing 20 mmol/L Hepes, 0.1 mg/mL BSA, and 1% Triton X-100 and 10% glycerol (vol/vol). Nonspecific binding was determined as the amount of radioactivity binding in the presence of 300-fold excess unlabeled PDGF-B. Binding data were analyzed with Prism4 software (GraphPad Software, www.graphpad.com).
RESULTS
Isolation of bovine glomerular capillary endothelial cells
Our attempts to isolate glomerular capillary endothelial cells were successful in bovine, but not in rat, glomeruli. Bovine capillary endothelial cells were identified from collagenase-digested glomeruli by uptake of DiI-labeled ac-LDL and positive cells identified by FACS were established in culture. Postsort analysis confirmed a high degree of purity (typically 97%) and the endothelial cell phenotype was further confirmed by typical morphology, positive vWF and negative a-SMA staining. Cultures remained 97% pure at passage 20, as assessed by repeat FACS analysis. Previous methodologies to isolate endothelial cells have employed double dilution cloning in order to separate endothelial cells from other glomerular cells, particularly mesangial cells [27] . Our use of FACS sorting represents a substantial improvement in the time and effort required for isolation of glomerular endothelial cells.
Hypoxia increases glomerular capillary endothelial cell PDGF-B
Northern blot analysis showed that steady state PDGF-B transcripts increased after as little as 1 hour of hypoxia and remained elevated compared to normoxic timematched controls through 32 hours of hypoxia (Fig. 1A) . Densitometric analysis of four independent experiments (Fig. 1B ) revealed up to a twofold increase in PDGF-B message in hypoxic cells compared to normoxic timematched controls, although the timing of the increase varied among experiments. In order to determine whether the increase in steady-state levels of PDGF-B resulted from increased gene transcription, we treated cells with actinomycin D. Densitometry showed a similar degree of reduction compared to controls in PDGF-B mRNA levels from actinomycin D-treated normoxic or hypoxic endothelial cells (Fig. 1C) . These results raise the possibility of a transcriptional regulation of PDGF-B by hypoxia. To assess whether hypoxia also increases PDGF-B protein, we immunoblotted whole cell lysates from glomerular endothelial cells exposed to 1 to 24 hours of hypoxia. As seen in Figure 2 , PDGF-B protein levels are increased Although endothelial cells were subjected to 1.5% O 2 up to 32 hours, cells were not toxic as demonstrated by only a 1% difference in lactate dehydrogenase (LDH) levels in hypoxic and normoxic cells (data not shown). Additionally, although the levels of oxygen we studied were low, other investigators have studied the effects of similarly low oxygen in a number of cell types [29] [30] [31] .
PDGF-B gene transcription in hypoxic endothelial cells is not mediated by HIF-1a or VEGF
Because the PDGF-B gene promoter has putative HIF1a binding sites, we investigated whether HIF-1a was responsible for the up-regulation of PDGF-B in hypoxic glomerular endothelial cells. We did not detect a difference in nuclear HIF-1a levels between normoxic and hypoxic cells (data not shown). To confirm our results, we additionally stimulated normoxic endothelial cells with desferrioximine, nickel, or cobalt chloride which are hypoxia mimetics that stabilize HIF-1a. Northern blot analyses failed to demonstrate induction of PDGF-B message in stimulated cells compared to controls (data not shown).
VEGF is a hypoxia-inducible cytokine, with its gene transcription regulated by HIF-1a. Since VEGF also regulates the expression of PDGF-B [32] , we investigated whether increased PDGF-B transcripts in hypoxic endothelial cells were due to increased VEGF. We performed Northern blots for VEGF on total RNA isolated from cells exposed to hypoxia for 2 to 32 hours and time-matched normoxic controls. We analyzed results from two independent experiments by densitometry, but as might be anticipated from the negative HIF-1a data, VEGF levels were either the same, or modestly diminished in hypoxic endothelial cells (data not shown).
Hypoxia increases mesangial cell responsiveness to exogenous PDGF-B
Because hypoxia of the glomerulus also would affect mesangial cells, we further investigated whether hypoxia influences the degree of PDGF-B responses in these cells. We first examined the proliferative response of normoxic and hypoxic mesangial cells stimulated with PDGF-B. We observed a dose-dependent increase in 3 Hthymidine incorporation in both normoxic and hypoxic mesangial cells, but at higher doses, the magnitude of increase was significantly higher in hypoxic cells (Fig. 3) . At 10 ng/mL, PDGF stimulated a 4.1 ± 0.42-fold increase in 3 H-thymidine incorporation in normoxic cells compared to nontreated controls. However, hypoxic cells stimulated with PDGF-B demonstrated an 8.6 ± 2.8-fold increase in 3 H-thymidine incorporation compared to unstimulated hypoxic controls. At 20 ng/mL, PDGF-B induced a 6.1 ± 2.3-fold increase in normoxic cells, whereas in hypoxic cells, it achieved a 20.0 ± 9.6-fold increase in 3 H-thymidine incorporation. These differences in PDGFstimulated proliferation between normoxic and hypoxic cells were significant (P = 0.01) (N = 4). We confirmed these results by counting cells in untreated or PDGF-Bstimulated normoxic and hypoxic mesangial cells. In two independent experiments, whereas PDGF-B stimulation increased cell number in both normoxia and hypoxia, the increase in numbers of hypoxic cells was threefold higher than in normoxic cells (data not shown).
To study whether a more modest degree of hypoxia also increased mesangial cell proliferative responses to PDGF-B, we performed dose-response experiments in mesangial cells subjected to 3% oxygen. Similar to the responses observed at 1.5% oxygen, PDGF-B stimulated a two-to threefold higher incorporation of 3 H-thymidine in hypoxic, compared to normoxic, cells (N = 2) (data not shown).
We next investigated whether hypoxia also increased the chemotactic response of mesangial cells to PDGF-B. As seen in Figure 4 , hypoxic mesangial cells migrated more promptly compared to normoxic controls. In six independent experiments, hypoxic cells migrated more promptly than normoxic controls with a mean 36-fold increase in numbers of migrated cells at 30 minutes. The number of migrated hypoxic cells was increased 6.4-and twofold compared to normoxic controls at 60 and 90 minutes, respectively. Because both the time to migration and numbers of migrated normoxic and hypoxic cells varied among experiments, we were not able to demonstrate statistical significance.
As with the glomerular endothelial cells, mesangial cells tolerated the hypoxic conditions without toxicity, as shown by the same negligible increase in LDH levels.
Hypoxia stimulates increased mesangial cell migration in response to PDGF-B produced by hypoxic glomerular capillary endothelial cells
In order to investigate the possibility of a hypoxiaregulated PDGF-B paracrine interaction between glomerular capillary endothelial and mesangial cells, we studied the migration of mesangial cells stimulated with medium conditioned by endothelial cells. As shown in . Hypoxic mesangial cells were similarly allowed to migrate in response to conditioned medium from hypoxic endothelial cells incubated with either neutralizing antibody or vehicle. Migrated cells were counted as in Fig. 4 and are expressed as fold increase of normoxic cells migrating to normoxic conditioned medium ± SEM (N = 5). * P < 0.0001 and * * P < 0.05 compared to normoxic cells migrating to normoxic conditioned medium; * * * P < 0.0001 compared to hypoxic cells migrating to hypoxic conditioned medium. Figure 5 , conditioned medium from hypoxic endothelial cells stimulated a significantly greater migration of hypoxic mesangial cells than did medium from normoxic endothelial cells when used to stimulate normoxic mesangial cells (11.7 ± 5.5-fold increase) (N = 5) (P < 0.05). The major chemotactic factor in the hypoxic conditioned medium appeared to be PDGF-B, since preincubation of the medium with a neutralizing antibody to PDGF-B markedly diminished, and in some experiments completely abrogated, the migratory response [normoxic migration 0.24 ± 0.19) (P < 0.0001) and hypoxic migration 0.18 ± 0.17 (P < 0.05), both fold of migration stimulated by conditioned medium not preincubated with antibody]. Preincubation of conditioned media with IgG did not decrease migration of cells compared to conditioned medium alone (mean 1.5-fold increase in migrated cells compared to control) (N = 2) (data not shown). To determine whether increased PDGF-B bioactivity in medium conditioned by hypoxic endothelial cells merely reflected a greater number of cells, we assessed cell number by determining total cellular protein or by counting cells. Total cellular protein was 15% to 37% lower, and cell counts 12% to 21% lower in hypoxic cells compared to normoxic controls. Thus, hypoxia increases PDGF-B production on a per cell basis in endothelial cells.
To investigate whether the enhanced hypoxic mesangial cell responses are mediated by HIF-1a, cells were treated with cobalt chloride or desferrioximine, and migration in response to endothelial cell-conditioned medium determined. Neither cobalt chloride-or desferrioximine-treated cells showed an increase in migration compared to control cells (227 control cells vs. 176 cobalt chloride-treated, or 192 desferrioximine-treated cells).
Hypoxia increases membrane-bound PDGF-b receptors and ligand affinity
Finally, we wanted to study the mechanism underlying enhanced PDGF-B responsiveness in hypoxic mesangial cells. We performed immunoblots for the PDGF-b receptor on whole cell lysates from cells exposed to hypoxia for increasing durations and from normoxic time-matched controls. As shown in Figure 6A , total cellular b receptor levels were similar in normoxic cells and cells exposed to as long 32 hours of hypoxia. We then performed saturation binding studies to determine whether hypoxia changes specific binding capacity. In hypoxic cells, specific binding capacity was increased (Fig. 6B) , with a significant mean 2.3-fold increase compared to normoxic cells (N = 4) (P ≤ 0.05).
DISCUSSION
We have demonstrated that hypoxia increases glomerular capillary endothelial cell PDGF transcripts and protein. We also report for the first time that hypoxia significantly amplifies the mitogenic and proliferative response of mesangial cells to exogenous PDGF. Furthermore, more hypoxic mesangial cells migrate in response to conditioned medium from hypoxic endothelial cells than normoxic mesangial cells do when cultured with medium from normoxic endothelial cells. The enhanced migration of the hypoxic cells is markedly decreased in the presence of PDGF-B neutralizing antibody. While hypoxia does not alter total cellular PDGF-b receptor levels, specific binding capacity is increased in hypoxic cells. These results demonstrate that hypoxia is a mediator of PDGF-B paracrine interactions between glomerular capillary endothelial and mesangial cells.
PDGF-B is critically important for vessel formation and glomerulogenesis during fetal life, as demonstrated by microaneurysm formation in capillary beds and the complete absence of mesangial cells in PDGF-B null mice [1] . Fetal mesangial cells themselves produce PDGF-B, which could act in an autocrine fashion. However, we did not observe an increase in proliferation of mesangial cells when they were stimulated with medium conditioned from hypoxic mesangial cells (data not shown), and our results are consistent with a previous report suggesting that mesangial cell PDGF-B is not increased by hypoxia [33] . Most importantly, the studies from Lindahl et al [3] and Bjarnegard et al [5] have demonstrated that endothelial cells are the important source of PDGF-B during glomerulogenesis. However, the regulation of glomerular capillary endothelial cell PDGF-B during renal organogenesis has not been well studied. Our studies show that hypoxia is a modulator of glomerular endothelial PDGF-B. We additionally show that hypoxia also exaggerates the mesangial response to this important cytokine. The relevance of our in vitro studies is supported by the in vivo studies by Freeburg et al [12, 13] in the developing postnatal murine kidney. Staining for the chemical marker pimonidazole hydrochloride, which forms detectable protein adducts only under severely hypoxic conditions (<10 mm Hg O 2 ), was positive in the outer cortex, albeit not as strongly positive as in the tubules of the inner cortex. Using this indirect marker of hypoxia, their results suggest that low oxygen tension is present in the nephrogenic cortex, although the precise level of tissue oxygen is not known, and studies in embryonic kidneys, with potentially even lower levels of oxygen tension than in newborn kidneys, have not yet been reported.
Our findings may be relevant not only to the developing kidney, but also to disease states of the mature kidney. Endothelial cell damage occurs in many glomerular diseases. In cases of microthrombus formation, it is possible that endothelial cells downstream of the thrombus become hypoxic and might therefore increase their production of PDGF-B. In other forms of endothelial cell injury, however, it is less clear whether the endothelial cells themselves become hypoxic. Nevertheless, disruption of the glomerular microvasculature might be predicted to result in at least some degree of glomerular hypoxia [24] . In that regard, the impact of hypoxia on mesangial cell response to cytokines important in the development of glomerulosclerosis, such as PDGF-B, has not been studied. We have demonstrated that hypoxia up-regulates PDGF-mediated cellular proliferation, an important early step in the development of many glomerular diseases. We are currently investigating whether hypoxia similarly enhances matrix production, the hallmark of glomerulosclerosis. While much investigation properly has focused on the inhibition of PDGF-B production to limit the degree of sclerosis, our results suggest that additionally abrogating the exaggerated response of hypoxic mesangial cells to PDGF-B might prove to be a beneficial adjuvant strategy in treating glomerular diseases.
A number of questions arise from our studies. Although hypoxia modestly stimulates glomerular endothelial PDGF-B, we do not know whether this is a direct effect, or whether hypoxia stimulates other effectors which then activate the PDGF-B gene. In regard to a direct effect, nuclear run-off studies would provide formal proof for a transcriptional up-regulation of the PDGF-B gene suggested by our actinomycin D experiments. In investigating potential transactivators, we did not detect increased nuclear levels of HIF-1a, despite putative binding sites in the PDGF-B promoter. We previously showed that NF-kB, another hypoxia-regulated transactivator, increases endothelial PDGF-B [28] . However, levels of NF-kB, as well as another oxygen-sensitive PDGF-B transcription factor c-jun, were not different between normoxic and hypoxic cells (data not shown). Since this short list is by no means exhaustive, promoter reporter studies interrupting the PDGF-B gene promoter would be helpful in identifying the mediator(s) stimulated by hypoxia. Second, it seems likely that hypoxiaindependent factors regulate endothelial PDGF-B expression during development, but the identity of these other modulators is unknown. TGF-b [8] and bFGF [9] are both important developmental cytokines that regulate PDGF-B, and since they are present during renal organogenesis, would be reasonable candidates. Third, the mechanism(s) responsible for the enhanced mesangial cell responses to hypoxia remains to be defined fully. Our results show that hypoxia does not increase steadystate basal levels of the PDGF-b receptor, but in PDGF-B-stimulated hypoxic cells, specific binding capacity is increased. We are currently investigating whether hypoxia itself increases redistribution of receptors to the membrane or whether hypoxia alters degradation of the ligand-bound hypoxic receptor. Additionally, how hypoxia influences the intracellular signaling pathways leading to increased migration and proliferation remains to be explored.
CONCLUSION
We have provided evidence for a hypoxia-mediated pathway that may be important in both fetal life and the pathogenesis of disease in the adult. The current understanding of glomerular vascular development is that relatively low oxygen tension stimulates podocytes to express VEGF which recruits endothelial cells to the glomerulus. We propose that relatively low oxygen tension further contributes to glomerulogenesis by amplifying the PDGF-B paracrine interactions between glomerular endothelial and mesangial cells. Hypoxia increases glomerular capillary endothelial expression of PDGF-B which attracts mesangial cells and hypoxia augments the migratory and proliferative response of mesangial cells to PDGF-B. Once vessel formation is complete, relatively low oxygen tension, and presumably also the amplification of the PDGF-B paracrine system, ceases. In diseases of the adult, however, hypoxia resulting from insults to the endothelium continues unabated, contributing to pathogenic mechanisms, including those mediated by PDGF-B.
